Intensity Therapeutics (INTS) announced that it has received formal notice from the Listings Qualifications staff of The Nasdaq Stock Market that the company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. Nasdaq confirmed that for the last 10 consecutive business days, from February 19 through March 4, the closing bid price of the company’s common stock was at or above $1.00, and as a result, the matter is now closed.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INTS:
- Intensity Therapeutics Inc trading halted, news pending
- Upcoming Stock Splits This Week (February 17 to February 20) – Stay Invested
- Intensity Therapeutics Announces 1-for-25 Reverse Stock Split
- Intensity Therapeutics announces reverse stock split
- Intensity Therapeutics to ‘opportunistically raise additional capital’ in 2026